Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

http://www.wikidata.org/entity/Q35818203

about

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines Immune checkpoint blockade in ovarian cancer Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy Adoptive immunotherapy against ovarian cancer Adoptive T-cell therapy for cancer: The era of engineered T cells Translational implications of tumor heterogeneity B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look Acquired and intrinsic resistance in cancer immunotherapy Immunotherapy in endometrial cancer - an evolving therapeutic paradigm Tumor infiltrating lymphocytes in ovarian cancer Clinical significance of tumor-infiltrating lymphocytes in breast cancer The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review.IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.Immunological parameters as a new lead in the diagnosis of ovarian cancer.Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment.A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.Digital genomic quantification of tumor-infiltrating lymphocytes.Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer.Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities.Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.Immunotherapeutic approaches to ovarian cancer treatment.STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.Molecular staging of gynecological cancer: What is the future?Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model.HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.The impact of inflammatory cells in malignant ascites on small intestinal ICCs' morphology and function Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma.

P2860

Q26738680-B9F56079-8BAD-4C97-929E-F6E45D93C9B0 Q26739825-34D03D64-C955-4D72-962C-3C6A099CAC61 Q26745516-8714F32F-ADC9-421D-93FF-0F52DBC726D3 Q26748905-CDFDA0BF-F593-4E19-8BC1-0D1FC4844894 Q26800611-DD798EC4-3317-49DC-A3B5-30A7ED31566F Q26822823-971D4FFE-5802-4152-AF71-4128F7C7E26C Q26824446-18FFB3A3-62C8-47D0-8792-5FD0F8EC4CF1 Q26827701-F9DA5C65-1200-49D5-85DA-B8A3C3B73C26 Q27020910-F87A161C-C92F-4115-8DEB-06B27B5D1062 Q27021878-5B82D355-809E-41CD-8697-AA3381B03603 Q28070214-F0F25C37-320C-4C93-86C2-794A5FB781A4 Q28076473-8DF6C1AD-FB83-43CC-B202-A8C76EF60CAF Q28119095-AA85719B-C8A9-43F7-8BB3-31D11F2192CA Q28238067-279ADF77-706D-4E0B-8761-7E98718F621A Q30244418-76B69D21-0CF6-4F03-9EE7-E5E2C6A2FF42 Q30355682-B950C827-8B2D-4027-85B5-B29A692EA48A Q30414037-9CBBCC91-8C76-4400-B65B-845893C79F3C Q33564510-D9FC5462-26C9-423F-986D-DEFE07D383AE Q33606150-23CBB065-DBF8-4E57-BD78-4EE5CE645393 Q33608191-98454B6B-F709-450E-B0C1-9115ECC6FE65 Q33631158-508A0694-F8BB-4D6E-BDDE-0A9AF1603A6D Q33750160-64344076-AD17-4C59-8934-51C27E0821EC Q33754724-323BD73A-4BB2-4432-9824-2A1AD6F4C847 Q33765767-CC89FF13-0FBC-4F9A-B5C0-E5EC3EFFD29B Q33786353-01797517-CF68-4703-8B8C-B1414FAEABCD Q33916814-D05C9325-6D33-4EFC-80F5-D15CF47424B4 Q34476278-4EF13668-C5B0-4AA1-8089-30C8052B5D29 Q34552079-2D380F07-2AB3-482D-B280-08CB1969A454 Q34586937-2D98B302-FCFF-456D-80FB-5A7A668BAEEA Q35012503-E7FE631E-208F-4EE3-8BF0-FEC3CA63218F Q35213535-4C17E9B9-D6A0-467B-BE7A-05093134CFD9 Q35263440-FE487079-579C-4058-93F3-88F2D5B99754 Q35677893-C6A8949F-9338-4939-9BD3-5BDCD7C18FB9 Q35940829-15C9F6CE-F5A0-4F4C-906C-48224597D0A5 Q35984198-E85488A6-1B8E-4F0D-BB32-64DE1DE7BC86 Q35996647-FB17AC2A-8114-489C-96DB-AD018EE1575C Q36057470-A8E138F4-B91B-4A38-90E1-B0DD0C8BD3E2 Q36060319-B88BA4F9-30BB-433D-A111-211E174055C3 Q36060333-2F97732F-021C-44CC-860F-38F520067DD7 Q36261405-99F92AD7-6F32-4E9E-A368-9725FD519631

P2860

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

http://www.wikidata.org/entity/Q35818203

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

@ast

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

@en

type

label

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

@ast

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

@en

prefLabel

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

@ast

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

@en

P1433

Q35818203-E0E66F72-254C-4851-A843-F8202293D32C

P1476

Q35818203-91D6C6DB-C4DB-4662-954B-4F86474078DE

P2093

Q35818203-2EE618D6-5A82-4F09-925C-C100E65C88D5

Q35818203-DD2F6230-3601-44E5-B234-061208F9C5BB

Q35818203-FD8E0B8A-334B-40AF-9301-944EAC26C796

P2860

Q35818203-01936D9C-009E-4083-8982-89B0B0D7B0B5

Q35818203-065F1FE8-1748-4465-9368-B58DE99D21F9

Q35818203-1270406E-DD6D-41F4-8B89-5AD27845179A

Q35818203-150155F6-364F-4C43-95C0-C214766599D9

Q35818203-32C4F101-58AA-4B2B-BD87-9302F45E6A96

Q35818203-347AA78D-2773-426B-9FCA-9AAD09BFEA4B

Q35818203-47F3ADD6-0814-4E70-A09B-C49DDE38509F

Q35818203-490BAA9A-4887-4E22-BE7E-A47C956B570D

Q35818203-4B0A0037-BC43-4A9D-A58F-3E0AD9E202F7

Q35818203-539C1FB7-EC04-4785-A124-FCDF2F145BE1

P304

Q35818203-752C0793-BF9A-4656-B1D9-55A2C725531A

P31

Q35818203-43202208-05F2-4A56-B593-91C34CA570DD

Q35818203-97c9982c-6e0a-4f32-9f5a-5f4fba8017bc

P356

Q35818203-D82922DA-9B44-4538-BBA6-D6572CC4E001

P407

Q35818203-E1917AD9-00AA-4E9A-9AA4-5531B26341EE

P433

Q35818203-E24BECB8-A34A-4026-BD63-2707E9EE9E7F

P478

Q35818203-ABAF713C-FFA4-4593-A767-7C8F54A51B9B

P50

Q35818203-68F1C1D3-9AB2-405E-92D6-671C8DB8F0C1

Q35818203-DD760EE8-8DA7-4960-BAC4-F9A4E60D7AA3

P577

Q35818203-309AB6F7-D2D0-4E67-A103-C13D9A3CAD9D

P5875

Q35818203-C622D78A-D93B-4314-8E57-22F76525F252

P698

Q35818203-69112C1C-835E-431B-A9E9-156431893624

P921

Q35818203-77FA6481-18AC-4774-A15C-33A5C180260F

Q35818203-7CA21D92-3DE5-4B3F-B8E3-D4CEF61C3934

P932

Q35818203-7ED964E1-B58A-4C4A-B448-211F537080A3

P356

J.YGYNO.2011.09.039

P1433

Gynecologic Oncology

P1476

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis

@en

P2093

Emin Tahirovic

http://www.w3.org/2001/XMLSchema#string

Sarah F Adams

http://www.w3.org/2001/XMLSchema#string

Wei-Ting Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Operating characteristics of a rank correlation test for publication bias

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

P304

192-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2011.09.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51758210

http://www.w3.org/2001/XMLSchema#string

P698

22040834

http://www.w3.org/2001/XMLSchema#string

P921

P932

3298445

http://www.w3.org/2001/XMLSchema#string